Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Cell Rep ; 42(12): 113574, 2023 12 26.
Artigo em Inglês | MEDLINE | ID: mdl-38100356

RESUMO

Multiple sclerosis (MS) is an inflammatory disease characterized by myelin loss. While therapies exist to slow MS progression, no treatment currently exists for remyelination. Remyelination, linked to reduced disability in MS, relies on microglia and monocyte-derived macrophages (MDMs). This study aims to understand the role of microglia during remyelination by lineage tracing and depleting them. Microglial lineage tracing reveals that both microglia and MDMs initially accumulate, but microglia later dominate the lesion. Microglia and MDMs engulf equal amounts of inhibitory myelin debris, but after microglial depletion, MDMs compensate by engulfing more myelin debris. Microglial depletion does, however, reduce the recruitment and proliferation of oligodendrocyte progenitor cells (OPCs) and impairs their subsequent differentiation and remyelination. These findings underscore the essential role of microglia during remyelination and offer insights for enhancing this process by understanding microglial regulation of remyelination.


Assuntos
Doenças Desmielinizantes , Esclerose Múltipla , Remielinização , Humanos , Bainha de Mielina/patologia , Microglia/patologia , Doenças Desmielinizantes/patologia , Macrófagos/patologia , Esclerose Múltipla/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA